Sapporo Clinical Laboratory Inc. (JASDAQ:9776) announces a share repurchase program. Under the program, the company will repurchase up to 16,300 shares, representing 0.48% of its issued share capital (excluding treasury stock), for a total purchase price of ¥25.92 million. The shares will be repurchased at a price of ¥1,590 per share. The purpose of the program is to carry out agile capital policy in response to changes in the business environment. As of June 21, 2021, the company has 3,423,278 issued shares (excluding treasury stock) and 792,722 treasury shares.